These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17981793)

  • 1. Role of alpha3 domain of class I MHC molecules in the activation of high- and low-avidity CD8+ CTLs.
    Belyakov IM; Kozlowski S; Mage M; Ahlers JD; Boyd LF; Margulies DH; Berzofsky JA
    Int Immunol; 2007 Dec; 19(12):1413-20. PubMed ID: 17981793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions.
    Shen L; Potter TA; Kane KP
    J Exp Med; 1996 Nov; 184(5):1671-83. PubMed ID: 8920857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules.
    Newberg MH; Smith DH; Haertel SB; Vining DR; Lacy E; Engelhard VH
    J Immunol; 1996 Apr; 156(7):2473-80. PubMed ID: 8786307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M; Pendleton CD; Berzofsky JA
    J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
    Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J
    Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avidity of CD8 T cells sharpens immunodominance.
    Dzutsev AH; Belyakov IM; Isakov DV; Margulies DH; Berzofsky JA
    Int Immunol; 2007 Apr; 19(4):497-507. PubMed ID: 17376783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degenerate MHC restriction reveals the contribution of class I MHC molecules in determining the fine specificity of CTL recognition of an immunodominant determinant of HIV-1 gp160 V3 loop.
    Shirai M; Kozlowski S; Margulies DH; Berzofsky JA
    J Immunol; 1997 Apr; 158(7):3181-8. PubMed ID: 9120272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of conserved regions of class I MHC molecules in the activation of CD8+ cytotoxic T lymphocytes by peptide and purified cell-free class I molecules.
    Takeshita T; Kozlowski S; England RD; Brower R; Schneck J; Takahashi H; DeLisi C; Margulies DH; Berzofsky JA
    Int Immunol; 1993 Sep; 5(9):1129-38. PubMed ID: 8241055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
    Shirai M; Vacchio MS; Hodes RJ; Berzofsky JA
    J Immunol; 1993 Aug; 151(4):2283-95. PubMed ID: 7688397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive inhibition in vivo and skewing of the T cell repertoire of antigen-specific CTL priming by an anti-peptide-MHC monoclonal antibody.
    Chung DH; Belyakov IM; Derby MA; Wang J; Boyd LF; Berzofsky JA; Margulies DH
    J Immunol; 2001 Jul; 167(2):699-707. PubMed ID: 11441073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species specificity in the interaction of CD8 with the alpha 3 domain of MHC class I molecules.
    Newberg MH; Ridge JP; Vining DR; Salter RD; Engelhard VH
    J Immunol; 1992 Jul; 149(1):136-42. PubMed ID: 1607650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymus leukemia antigen (TL)-specific cytotoxic T lymphocytes recognize the alpha1/alpha2 domain of TL free from antigenic peptides.
    Tsujimura K; Obata Y; Kondo E; Nishida K; Matsudaira Y; Akatsuka Y; Kuzushima K; Takahashi T
    Int Immunol; 2003 Nov; 15(11):1319-26. PubMed ID: 14565930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of rapid apoptosis for class I MHC molecule-restricted CD8(+) HIV-1 gp160-specific murine activated CTLs by free antigenic peptide in vivo.
    Nakagawa Y; Shimizu M; Norose Y; Takahashi M; Takahashi H
    Int Immunol; 2013 Jan; 25(1):11-24. PubMed ID: 22945875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein.
    Takahashi H; Houghten R; Putney SD; Margulies DH; Moss B; Germain RN; Berzofsky JA
    J Exp Med; 1989 Dec; 170(6):2023-35. PubMed ID: 2479705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U; Schoel B; Kaufmann SH
    J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
    Asnagli H; Schmitt-Verhulst AM; Guimezanes A
    J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD8alphabeta co-receptor on double-positive thymocytes binds with differing affinities to the products of distinct class I MHC loci.
    Moody AM; Xiong Y; Chang HC; Reinherz EL
    Eur J Immunol; 2001 Sep; 31(9):2791-9. PubMed ID: 11536178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic properties.
    Bristol JA; Schlom J; Abrams SI
    J Immunol; 1998 Mar; 160(5):2433-41. PubMed ID: 9498787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Threshold tolerance in H-2Kb-specific TCR transgenic mice expressing mutant H-2Kb: conversion of helper-independent to helper-dependent CTL.
    Auphan N; Jézo-Brémond A; Schönrich G; Hämmerling G; Arnold B; Malissen B; Schmitt-Verhulst AM
    Int Immunol; 1992 Dec; 4(12):1419-28. PubMed ID: 1286065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.